{"title":"富氮氮化钼具有 CD39 核苷酸酶的内在活性","authors":"Xiaomin Zhang, Chunqiu Xia, Liangqia Guo","doi":"10.1002/smll.202407648","DOIUrl":null,"url":null,"abstract":"<p><p>CD39 is one of the important nucleotidases to adjust extracellular adenosine triphosphate (ATP) and adenosine diphosphate (ADP) concentration. However, the enzyme mimics to simulate the activity of CD39 still remains to be explored. Herein nitrogen-rich molybdenum nitride (Mo<sub>5</sub>N<sub>6</sub>) nanosheets are explored to possess CD39-like activity, which are able to catalyze the hydrolysis of the high-energy phosphate bonds (HEPBs) in ATP and ADP but not the common phosphate bonds in adenosine monophosphate (AMP). The catalytic hydrolysis of the phosphate bond over Mo<sub>5</sub>N<sub>6</sub>-700 nanosheets is first investigated using para-nitrophenyl phosphate as the model substrate and then the CD39-like activity is further explored and verified by <sup>31</sup>p NMR spectroscopy. Mo<sup>4+</sup> on the surface of Mo<sub>5</sub>N<sub>6</sub>-700 nanosheets are the catalytic active sites. Using ATP as the model substrate, the K<sub>m</sub> and V<sub>max</sub> values of CD39-like activity at optimal pH 9.0 are 3.2 µmol L<sup>-1</sup> and 18.5 µmol L<sup>-1</sup> h<sup>-1</sup>, respectively. The CD39-like activity of Mo<sub>5</sub>N<sub>6</sub>-700 nanosheets enabled the down-regulation of intracellular ATP concentration to a larger degree for cancer cells than normal cells, which makes Mo<sub>5</sub>N<sub>6</sub>-700 nanosheets a potential therapeutic reagent for cancers.</p>","PeriodicalId":228,"journal":{"name":"Small","volume":" ","pages":"e2407648"},"PeriodicalIF":13.0000,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Nitrogen-Rich Molybdenum Nitride with Intrinsic CD39 Nucleotidase Activity.\",\"authors\":\"Xiaomin Zhang, Chunqiu Xia, Liangqia Guo\",\"doi\":\"10.1002/smll.202407648\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>CD39 is one of the important nucleotidases to adjust extracellular adenosine triphosphate (ATP) and adenosine diphosphate (ADP) concentration. However, the enzyme mimics to simulate the activity of CD39 still remains to be explored. Herein nitrogen-rich molybdenum nitride (Mo<sub>5</sub>N<sub>6</sub>) nanosheets are explored to possess CD39-like activity, which are able to catalyze the hydrolysis of the high-energy phosphate bonds (HEPBs) in ATP and ADP but not the common phosphate bonds in adenosine monophosphate (AMP). The catalytic hydrolysis of the phosphate bond over Mo<sub>5</sub>N<sub>6</sub>-700 nanosheets is first investigated using para-nitrophenyl phosphate as the model substrate and then the CD39-like activity is further explored and verified by <sup>31</sup>p NMR spectroscopy. Mo<sup>4+</sup> on the surface of Mo<sub>5</sub>N<sub>6</sub>-700 nanosheets are the catalytic active sites. Using ATP as the model substrate, the K<sub>m</sub> and V<sub>max</sub> values of CD39-like activity at optimal pH 9.0 are 3.2 µmol L<sup>-1</sup> and 18.5 µmol L<sup>-1</sup> h<sup>-1</sup>, respectively. The CD39-like activity of Mo<sub>5</sub>N<sub>6</sub>-700 nanosheets enabled the down-regulation of intracellular ATP concentration to a larger degree for cancer cells than normal cells, which makes Mo<sub>5</sub>N<sub>6</sub>-700 nanosheets a potential therapeutic reagent for cancers.</p>\",\"PeriodicalId\":228,\"journal\":{\"name\":\"Small\",\"volume\":\" \",\"pages\":\"e2407648\"},\"PeriodicalIF\":13.0000,\"publicationDate\":\"2024-11-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Small\",\"FirstCategoryId\":\"88\",\"ListUrlMain\":\"https://doi.org/10.1002/smll.202407648\",\"RegionNum\":2,\"RegionCategory\":\"材料科学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MULTIDISCIPLINARY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Small","FirstCategoryId":"88","ListUrlMain":"https://doi.org/10.1002/smll.202407648","RegionNum":2,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
Nitrogen-Rich Molybdenum Nitride with Intrinsic CD39 Nucleotidase Activity.
CD39 is one of the important nucleotidases to adjust extracellular adenosine triphosphate (ATP) and adenosine diphosphate (ADP) concentration. However, the enzyme mimics to simulate the activity of CD39 still remains to be explored. Herein nitrogen-rich molybdenum nitride (Mo5N6) nanosheets are explored to possess CD39-like activity, which are able to catalyze the hydrolysis of the high-energy phosphate bonds (HEPBs) in ATP and ADP but not the common phosphate bonds in adenosine monophosphate (AMP). The catalytic hydrolysis of the phosphate bond over Mo5N6-700 nanosheets is first investigated using para-nitrophenyl phosphate as the model substrate and then the CD39-like activity is further explored and verified by 31p NMR spectroscopy. Mo4+ on the surface of Mo5N6-700 nanosheets are the catalytic active sites. Using ATP as the model substrate, the Km and Vmax values of CD39-like activity at optimal pH 9.0 are 3.2 µmol L-1 and 18.5 µmol L-1 h-1, respectively. The CD39-like activity of Mo5N6-700 nanosheets enabled the down-regulation of intracellular ATP concentration to a larger degree for cancer cells than normal cells, which makes Mo5N6-700 nanosheets a potential therapeutic reagent for cancers.
期刊介绍:
Small serves as an exceptional platform for both experimental and theoretical studies in fundamental and applied interdisciplinary research at the nano- and microscale. The journal offers a compelling mix of peer-reviewed Research Articles, Reviews, Perspectives, and Comments.
With a remarkable 2022 Journal Impact Factor of 13.3 (Journal Citation Reports from Clarivate Analytics, 2023), Small remains among the top multidisciplinary journals, covering a wide range of topics at the interface of materials science, chemistry, physics, engineering, medicine, and biology.
Small's readership includes biochemists, biologists, biomedical scientists, chemists, engineers, information technologists, materials scientists, physicists, and theoreticians alike.